91-19-0 | Quinoxaline

Packsize	Purity	Availability	Price	Discounted Price
5g	97%	in stock	$6.00	$4.00
10g	97%	in stock	$10.00	$7.00
25g	97%	in stock	$19.00	$14.00
100g	97%	in stock	$47.00	$33.00
500g	97%	in stock	$118.00	$83.00

Description

• Catalog Number: AB78782
• Chemical Name: Quinoxaline
• CAS Number: 91-19-0
• Molecular Formula: C8H6N2
• Molecular Weight: 130.1466
• MDL Number: MFCD00006719
• SMILES: c1ccc2c(c1)nccn2

Computed Properties

• Complexity: 99.8
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 10
• Hydrogen Bond Acceptor Count: 2
• XLogP3: 1.3

Literature

• Quinoxaline derivatives: a patent review (2006--present).

  Expert opinion on therapeutic patents 20121101

• Multisubstituted quinoxalines and pyrido[2,3-d]pyrimidines: synthesis and SAR study as tyrosine kinase c-Met inhibitors.

  Bioorganic & medicinal chemistry letters 20121015

• Tetrathiafulvalene-fused porphyrins via quinoxaline linkers: symmetric and asymmetric donor-acceptor systems.

  Chemphyschem : a European journal of chemical physics and physical chemistry 20121008

• A facile three- and four-component procedure toward the synthesis of functionalized pyrano- and benzo[f]quinoxaline derivatives.

  Molecular diversity 20120801

• {1'-Phenyl-1',2',5',6',7',7a'-hexa-hydro-spiro-[indeno-[1,2-b]quinoxaline-11,3'-pyrrolizin]-2'-yl}(p-tol-yl)methanone.

  Acta crystallographica. Section E, Structure reports online 20120801

• 6,7-Dichloro-3-(2,4-dichloro-benz-yl)-quinoxalin-2(1H)-one.

  Acta crystallographica. Section E, Structure reports online 20120801

• Identification and quantification of six major α-dicarbonyl process contaminants in high-fructose corn syrup.

  Analytical and bioanalytical chemistry 20120701

• (4aR*,8aS*)-2,3-Diphenyl-4a,5,6,7,8,8a-hexa-hydro-quinoxaline.

  Acta crystallographica. Section E, Structure reports online 20120701

• Constructing organic D-A-π-A-featured sensitizers with a quinoxaline unit for high-efficiency solar cells: the effect of an auxiliary acceptor on the absorption and the energy level alignment.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20120625

• New quinoxaline derivatives as potential MT₁ and MT₂ receptor ligands.

  Molecules (Basel, Switzerland) 20120625

• Synthesis, structure, magnetic behavior, and theoretical analysis of diazine-bridged magnetic ladders: Cu(quinoxoline)X2 and Cu(2,3-dimethylpyrazine)X2 (X = Cl, Br).

  Inorganic chemistry 20120604

• 6-Chloro-2-phenyl-3-(2-phenyl-ethyn-yl)quinoxaline.

  Acta crystallographica. Section E, Structure reports online 20120601

• 2-(4-Fluoro-phen-yl)quinoxaline.

  Acta crystallographica. Section E, Structure reports online 20120601

• Gold-catalyzed 1,2-/1,2-bis-acetoxy migration of 1,4-bis-propargyl acetates: a mechanistic study.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20120529

• Chemistry of color formation during rooibos fermentation.

  Journal of agricultural and food chemistry 20120523

• Microwave-assisted solvent-free synthesis and in vitro antibacterial screening of quinoxalines and pyrido[2, 3b]pyrazines.

  Molecules (Basel, Switzerland) 20120504

• Steroidal C-21 heteroaryl thioethers. Part 3: pregn-4-eno-[3,2-c]pyrazole fused A ring modified steroids as selective glucocorticoid receptor modulators (dissociated steroids).

  Bioorganic & medicinal chemistry letters 20120501

• Tandem high-dose chemotherapy and autologous stem cell transplantation for anaplastic ependymoma in children younger than 3 years of age.

  Journal of neuro-oncology 20120401

• Carbonyl reduction of mequindox by chicken and porcine cytosol and cloned carbonyl reductase 1.

  Drug metabolism and disposition: the biological fate of chemicals 20120401

• Perturbing pro-survival proteins using quinoxaline derivatives: a structure-activity relationship study.

  Bioorganic & medicinal chemistry 20120401

• AlCl3 induced (hetero)arylation of 2,3-dichloroquinoxaline: a one-pot synthesis of mono/disubstituted quinoxalines as potential antitubercular agents.

  Bioorganic & medicinal chemistry 20120301

• Peptide-cleaving agents for human islet amyloid polypeptide containing substrate recognition site based on quinoxaline: cleavage efficiency enhanced by lowering substrate concentration.

  Bioorganic & medicinal chemistry letters 20120215

• HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC).

  Journal of pharmaceutical and biomedical analysis 20120205

• Synthesis, anticancer activity and pharmacokinetic analysis of 1-[(substituted 2-alkoxyquinoxalin-3-yl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives.

  Bioorganic & medicinal chemistry 20120201

• 2-Phenyl-thieno[2,3-b]quinoxaline.

  Acta crystallographica. Section E, Structure reports online 20120201

• Mechanistic insight into the cleavage of an aromatic C-C bond by tungsten.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20120116

• 1-Benzyl-3-methyl-3',5'-diphenyl-spiro-[quinoxaline-2(1H),2'(3'H)-1,3,4-thia-diazole].

  Acta crystallographica. Section E, Structure reports online 20120101

• 3-{2-[(3-{(E)-2-[4-(Dimethyl-amino)-phen-yl]ethen-yl}quinoxalin-2-yl)-oxy]eth-yl}-1,3-oxazolidin-2-one monohydrate.

  Acta crystallographica. Section E, Structure reports online 20120101

• 3-Carbamoylquinoxalin-1-ium chloride.

  Acta crystallographica. Section E, Structure reports online 20120101

• Development of an inflammation-associated colorectal cancer model and its application for research on carcinogenesis and chemoprevention.

  International journal of inflammation 20120101

• An efficient protocol for the synthesis of quinoxaline derivatives at room temperature using recyclable alumina-supported heteropolyoxometalates.

  TheScientificWorldJournal 20120101

• Identification of thioredoxin glutathione reductase inhibitors that kill cestode and trematode parasites.

  PloS one 20120101

• Methylglyoxal mediates adipocyte proliferation by increasing phosphorylation of Akt1.

  PloS one 20120101

• Innate immune response of human plasmacytoid dendritic cells to poxvirus infection is subverted by vaccinia E3 via its Z-DNA/RNA binding domain.

  PloS one 20120101

• Small molecule drug discovery at the glucagon-like peptide-1 receptor.

  Experimental diabetes research 20120101

• PARP-1 Val762Ala polymorphism is associated with risk of cervical carcinoma.

  PloS one 20120101

• Synthesis and neuropharmacological evaluation of some novel quinoxaline 2, 3-dione derivatives.

  TheScientificWorldJournal 20120101

• Electrochemical behavior of quinoxalin-2-one derivatives at mercury electrodes and its analytical use.

  TheScientificWorldJournal 20120101

• Development of quinoxaline 1, 4-dioxides resistance in Escherichia coli and molecular change under resistance selection.

  PloS one 20120101

• Novel insights into the maillard catalyzed degradation of maltose.

  Journal of agricultural and food chemistry 20111228

• Oxidative metabolism of a quinoxaline derivative by xanthine oxidase in rodent plasma.

  Chemical research in toxicology 20111219

• Unusual multi-step sequential Au(III)/Au(II) processes of gold(III) quinoxalinoporphyrins in acidic non-aqueous media.

  Inorganic chemistry 20111219

• Q39, a quinoxaline 1,4-Di-N-oxide derivative, inhibits hypoxia-inducible factor-1α expression and the Akt/mTOR/4E-BP1 signaling pathway in human hepatoma cells.

  Investigational new drugs 20111201

• Synthesis, in vitro antitubercular activity and 3D-QSAR of novel quinoxaline derivatives.

  Chemical biology & drug design 20111201

• 4-Chlorotetrazolo[1,5-a]quinoxaline inhibits activation of Syk kinase to suppress mast cells in vitro and mast cell-mediated passive cutaneous anaphylaxis in mice.

  Toxicology and applied pharmacology 20111201

• Discovery of novel anti-inflammatory drug-like compounds by aligning in silico and in vivo screening: the nitroindazolinone chemotype.

  European journal of medicinal chemistry 20111201

• Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H₃R and BACE 1 inhibitory activities.

  Bioorganic & medicinal chemistry 20111201

• A sensitive liquid chromatography coupled with mass spectrometry method for the intracellular and plasma quantification of raltegravir after solid-phase extraction.

  The Journal of pharmacy and pharmacology 20111201

• catena-Poly[[bis-(2,4-dichloro-benzoato)bis-(methanol-κO)cobalt(II)]-μ-4,4'-bipyridine-κN:N'].

  Acta crystallographica. Section E, Structure reports online 20111201

• N,N'-Bis(pyridin-2-yl)benzene-1,4-diamine-quinoxaline (2/1).

  Acta crystallographica. Section E, Structure reports online 20111201

• N,N'-Bis(pyridin-2-yl)benzene-1,4-diamine-naphthalene (2/1).

  Acta crystallographica. Section E, Structure reports online 20111201

• Synthesis, in vitro anticancer screening and radiosensitizing evaluation of some new 4-[3-(substituted)thioureido]-N-(quinoxalin-2-yl)-benzenesulfonamide derivatives.

  Acta pharmaceutica (Zagreb, Croatia) 20111201

• Synthesis and characterization of diiron dithiolate complexes containing a quinoxaline bridge.

  Dalton transactions (Cambridge, England : 2003) 20111107

• The mechanism of enzymatic and non-enzymatic N-oxide reductive metabolism of cyadox in pig liver.

  Xenobiotica; the fate of foreign compounds in biological systems 20111101

• (Phen-yl)(3-phenyl-sulfonyl-1,2-dihydro-pyrrolo-[1,2-a]quinoxalin-1-yl)methanone.

  Acta crystallographica. Section E, Structure reports online 20111101

• 1-Allyl-3-phenyl-quinoxalin-2(1H)-one.

  Acta crystallographica. Section E, Structure reports online 20111101

• Synthesis, structure and redox properties of bis(cyclopentadienyl)dithiolene complexes of molybdenum and tungsten.

  Dalton transactions (Cambridge, England : 2003) 20111028

• Thieno[3,2-b]pyrrolo donor fused with benzothiadiazolo, benzoselenadiazolo and quinoxalino acceptors: synthesis, characterization, and molecular properties.

  Organic letters 20111021

• New 2,3-disubstituted-5-hydroxyquinoxaline ligands and their coordination chemistry with cyclometallated iridium(III): syntheses, structures and tunable electronic properties.

  Dalton transactions (Cambridge, England : 2003) 20111007

• NRPS substrate promiscuity diversifies the xenematides.

  Organic letters 20111007

• Survey of 1,2-dicarbonyl compounds in commercial honey of different floral origin.

  Journal of food science 20111001

• Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H₄ and the ion channel serotonin 5-HT₃A.

  Bioorganic & medicinal chemistry letters 20110915

• Quinoxaline-embedded polyacenoquinone esters: synthesis, electronic properties, and crystal structure.

  Organic letters 20110902

• Toxic effects of nine polycyclic aromatic compounds on Enchytraeus crypticus in artificial soil in relation to their properties.

  Ecotoxicology and environmental safety 20110901

• Molecular quadrangle formation from a diuranium μ-η6,η6-toluene complex.

  Chemical communications (Cambridge, England) 20110828

• Palladium-catalyzed asymmetric allylic alkylations of polynitrogen-containing aromatic heterocycles.

  Journal of the American Chemical Society 20110817

• Synthesis of quinoxaline 1,4-di-N-oxide analogues and crystal structure of 2-carbomethoxy-3-hydroxyquinoxaline-di-N-oxide.

  Molecules (Basel, Switzerland) 20110812

• Synthesis and optical properties of acidochromic amine-substituted benzo[a]phenazines.

  The Journal of organic chemistry 20110805

• Two-step synthesis of hexaammonium triptycene: an air-stable building block for condensation reactions to extended triptycene derivatives.

  The Journal of organic chemistry 20110805

• Novel quinoxaline-based organic sensitizers for dye-sensitized solar cells.

  Organic letters 20110805

• New salicylamide and sulfonamide derivatives of quinoxaline 1,4-di-N-oxide with antileishmanial and antimalarial activities.

  Bioorganic & medicinal chemistry letters 20110801

• Novel quinoxaline derivatives for in vivo imaging of β-amyloid plaques in the brain.

  Bioorganic & medicinal chemistry letters 20110715

• Phospshoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: discovery and structure-activity relationships of a series of quinoline and quinoxaline derivatives.

  Journal of medicinal chemistry 20110714

• Triostin A derived hybrid for simultaneous DNA binding and metal coordination.

  Amino acids 20110701

• A review on various heterocyclic moieties and their antitubercular activity.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20110701

• New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-Mycobacterium tuberculosis agents.

  Bioorganic & medicinal chemistry letters 20110615

• Solution processable indoloquinoxaline derivatives containing bulky polyaromatic hydrocarbons: synthesis, optical spectra, and electroluminescence.

  The Journal of organic chemistry 20110603

• Quinoxaline derivative of oleanolic acid inhibits osteoclastic bone resorption and prevents ovariectomy-induced bone loss.

  Menopause (New York, N.Y.) 20110601

• Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent.

  European journal of medicinal chemistry 20110601

• N'-(3-Methyl-quinoxalin-2-yl)-N'-phenyl-benzohydrazide.

  Acta crystallographica. Section E, Structure reports online 20110601

• Disproportionation of dipyrrolylquinoxaline radical anions via the internal protons of the pyrrole moieties.

  Journal of the American Chemical Society 20110518

• Synthesis and evaluation of quinoxaline derivatives as potential influenza NS1A protein inhibitors.

  Bioorganic & medicinal chemistry letters 20110515

• Long-term mequindox treatment induced endocrine and reproductive toxicity via oxidative stress in male Wistar rats.

  Toxicology and applied pharmacology 20110501

• 3-{2-[(3-Phenyl-quinoxalin-2-yl)-oxy]ethyl}-1,3-oxazolidin-2-one.

  Acta crystallographica. Section E, Structure reports online 20110501

• Fourier transform microwave and millimeter wave spectroscopy of quinazoline, quinoxaline, and phthalazine.

  The Journal of chemical physics 20110421

• Synthesis and biological evaluation of new quinoxaline derivatives as antioxidant and anti-inflammatory agents.

  Chemical biology & drug design 20110401

• Trypanocidal properties, structure-activity relationship and computational studies of quinoxaline 1,4-di-N-oxide derivatives.

  Experimental parasitology 20110401

• 2,3-Substituted quinoxalin-6-amine analogs as antiproliferatives: a structure-activity relationship study.

  Bioorganic & medicinal chemistry letters 20110401

• Quinoxaline 1,4-di-N-oxide and the potential for treating tuberculosis.

  Infectious disorders drug targets 20110401

• High throughput screens yield small molecule inhibitors of Leishmania CRK3:CYC6 cyclin-dependent kinase.

  PLoS neglected tropical diseases 20110401

• catena-Poly[[tetra-aqua-[trans-1,2-bis-(4-pyrid-yl)ethene-κN:N']nickel(II)] dinitrate].

  Acta crystallographica. Section E, Structure reports online 20110401

• 2,3-Bis(1-methylimidazol-2-yl)quinoxaline (bmiq), a new ligand with decoupled electron transfer and metal coordination sites: the very different redox behaviour of isoelectronic complexes with [PtCl2] and [AuCl2]+.

  Dalton transactions (Cambridge, England : 2003) 20110328

• A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation.

  Journal of pharmaceutical and biomedical analysis 20110325

• Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT₃ receptor antagonists.

  Cancer chemotherapy and pharmacology 20110301

• Metabolites and JAK/STAT pathway were involved in the liver and spleen damage in male Wistar rats fed with mequindox.

  Toxicology 20110227

• Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress.

  Cellular and molecular life sciences : CMLS 20110201

• 3-Deoxygalactosone, a new glucose degradation product in peritoneal dialysis fluids: identification, quantification by HPLC/DAD/MSMS and its pathway of formation.

  Analytical and bioanalytical chemistry 20110201

• (Z)-1,2-Dichloro-1,2-bis-(3-chloro-quinoxalin-2-yl)ethene.

  Acta crystallographica. Section E, Structure reports online 20110201

• A radical pathway to synthesise Mo and W dithiolene complexes.

  Chemical communications (Cambridge, England) 20110121

• Towards echinomycin mimetics by grafting quinoxaline residues on glycophane scaffolds.

  Bioorganic & medicinal chemistry 20110115

• Microwave-assisted synthesis of quinoline, isoquinoline, quinoxaline and quinazoline derivatives as CB2 receptor agonists.

  Bioorganic & medicinal chemistry 20110115

• Organometallic anticancer compounds.

  Journal of medicinal chemistry 20110113

• In vitro biotransformation and investigation of metabolic enzymes possibly responsible for the metabolism of bisdesoxyolaquindox in the liver fractions of rats, chicken, and pigs.

  Toxicology 20110111

• Benzopyrazine derivatives: A novel class of growth factor receptor bound protein 7 antagonists.

  Bioorganic & medicinal chemistry 20110101

• Part I: Synthesis, cancer chemopreventive activity and molecular docking study of novel quinoxaline derivatives.

  European journal of medicinal chemistry 20110101

• Antioxidant, anti-inflammatory and anti-hyperglycaemic activities of heterocyclic homoprostanoid derivatives.

  Bioorganic & medicinal chemistry 20110101

• In silico quantitative structure-activity relationship studies on P-gp modulators of tetrahydroisoquinoline-ethyl-phenylamine series.

  BMC structural biology 20110101

• The use of endophytes to obtain bioactive compounds and their application in biotransformation process.

  Biotechnology research international 20110101

• Regulation of senescence in cancer and aging.

  Journal of aging research 20110101

• The synthesis and optical properties of fluorescent quinoxalines and of electrospun fibers containing fluorescent quinoxaline.

  Journal of nanoscience and nanotechnology 20110101

• Synthesis of new 2-substituted 6-bromo-3-methylthiazolo[3,2-alpha]-benzimidazole derivatives and their biological activities.

  Zeitschrift fur Naturforschung. C, Journal of biosciences 20110101

• Light-emitting devices with conjugated polymers.

  International journal of molecular sciences 20110101

• Synthesis and biological evaluation of some novel quinoxaline derivatives as anticonvulsant agents.

  Arzneimittel-Forschung 20110101

• Novel Phenazine 5,10-Dioxides Release OH in Simulated Hypoxia and Induce Reduction of Tumour Volume In Vivo.

  ISRN pharmacology 20110101

• DNA Interaction Studies of a New Platinum(II) Complex Containing Different Aromatic Dinitrogen Ligands.

  Bioinorganic chemistry and applications 20110101

• Increased renal methylglyoxal formation with down-regulation of PGC-1α-FBPase pathway in cystathionine γ-lyase knockout mice.

  PloS one 20110101

• Smell and taste disorders.

  GMS current topics in otorhinolaryngology, head and neck surgery 20110101

• Novel small molecule glucagon-like peptide-1 receptor agonist stimulates insulin secretion in rodents and from human islets.

  Diabetes 20101201

• 3-[2-(1H-Benzimidazol-2-ylsulfan-yl)eth-yl]-1,3-oxazolidin-2-one.

  Acta crystallographica. Section E, Structure reports online 20101201

• 1-Allyl-3-methyl-3',5'-diphenyl-spiro-[quinoxaline-2(1H),2'(3'H)-[1,3,4]thia-diazole].

  Acta crystallographica. Section E, Structure reports online 20101201

• Design of novel iron compounds as potential therapeutic agents against tuberculosis.

  Journal of inorganic biochemistry 20101101

• Quinoxaline: Z' = 1 form.

  Acta crystallographica. Section E, Structure reports online 20101101

• (1R,4S)-7,8-Dichloro-1,2,3,4-tetra-hydro-1,11,11-trimethyl-1,4-methano-phenazine.

  Acta crystallographica. Section E, Structure reports online 20101101

• E-2-[3-(3,4-dichlorophenyl)-1-oxo-2-propenyl]-3-methylquinoxaline-1,4-dioxide: a lead antitubercular agent which alters mitochondrial respiration in rat liver.

  European journal of medicinal chemistry 20101001

• Synthesis of new series of quinoxaline based MAO-inhibitors and docking studies.

  European journal of medicinal chemistry 20101001

• Bis(di-2-pyridyl-methane-diol-κN,O,N')nickel(II) dibenzoate.

  Acta crystallographica. Section E, Structure reports online 20101001

• 3-(4-Meth-oxy-phen-yl)pyrido[2,3-b]pyrazine.

  Acta crystallographica. Section E, Structure reports online 20101001

• Photophysical properties of dipeptides containing substituted 3-(quinoxalin-6-yl) alanine. Spectroscopic studies and theoretical calculations.

  The journal of physical chemistry. A 20100909

• HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions.

  Journal of pharmaceutical and biomedical analysis 20100905

• Correlation of pharmacokinetic features and tissue distribution with toxicity of Q39, a hypoxic cell cytotoxic agent.

  Die Pharmazie 20100901

• N-(3-Methyl-phen-yl)quinoxalin-2-amine monohydrate.

  Acta crystallographica. Section E, Structure reports online 20100901

• 1,2,3,4-Tetra-hydro-phenazine 5,10-dioxide.

  Acta crystallographica. Section E, Structure reports online 20100901

• 2-(3-Nitro-phen-oxy)quinoxaline.

  Acta crystallographica. Section E, Structure reports online 20100901

• Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma.

  Antimicrobial agents and chemotherapy 20100801

• Dibenzoatobis[3-(pyrrol-1-ylmeth-yl)pyridine]-zinc(II).

  Acta crystallographica. Section E, Structure reports online 20100801

• 2-Isopropyl-3-methyl-quinoxaline 1,4-dioxide.

  Acta crystallographica. Section E, Structure reports online 20100801

• 1-Benzyl-3-methyl-quinoxalin-2(1H)-one.

  Acta crystallographica. Section E, Structure reports online 20100801

• 2-(2-Chloro-phen-yl)-3-(3,4-dimeth-oxy-phen-yl)quinoxaline.

  Acta crystallographica. Section E, Structure reports online 20100801

• Investigation of reactive alpha-dicarbonyl compounds generated from the Maillard reactions of L-methionine with reducing sugars via their stable quinoxaline derivatives.

  Journal of agricultural and food chemistry 20100728

• Synthesis of 2-boryl- and silylindoles by copper-catalyzed borylative and silylative cyclization of 2-alkenylaryl isocyanides.

  The Journal of organic chemistry 20100716

• RNA internal loops with tandem AG pairs: the structure of the 5'GAGU/3'UGAG loop can be dramatically different from others, including 5'AAGU/3'UGAA.

  Biochemistry 20100713

• New quinoxaline 1, 4-di-N-oxides: anticancer and hypoxia-selective therapeutic agents.

  European journal of medicinal chemistry 20100701

• Potent and selective inhibition of polycythemia by the quinoxaline JAK2 inhibitor NVP-BSK805.

  Molecular cancer therapeutics 20100701

• Cocrystals of 2,3,5,6-tetrafluorobenzene-1,4-diol with diaza aromatic compounds.

  Acta crystallographica. Section C, Crystal structure communications 20100701

• 3-Methyl-1-(prop-2-en-1-yl)quinoxalin-2(1H)-one.

  Acta crystallographica. Section E, Structure reports online 20100701

• 2,3-Diphenyl-quinoxalin-1-ium chloride.

  Acta crystallographica. Section E, Structure reports online 20100701

• 2,3-Dimethyl-6-nitro-quinoxaline.

  Acta crystallographica. Section E, Structure reports online 20100701

• Naftifine-analogues as anti-Trypanosoma cruzi agents.

  European journal of medicinal chemistry 20100601

• Ultrasound-promoted greener synthesis of benzoheterocycle derivatives catalyzed by nanocrystalline copper(II) oxide.

  Ultrasonics sonochemistry 20100601

• 2-(4-Bromo-phen-yl)quinoxaline.

  Acta crystallographica. Section E, Structure reports online 20100601

• Pd-catalyzed C-N bond formation with heteroaromatic tosylates.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20100510

• Photoinduced tandem reactions of isoquinoline-1,3,4-trione with alkynes to build aza-polycycles.

  The Journal of organic chemistry 20100507

• Spermidine/spermine N1-acetyltranferase modulation by novel folate cycle inhibitors in cisplatin-sensitive and -resistant human ovarian cancer cell lines.

  Gynecologic oncology 20100501

• Studies of new peroxyoxalate-H2O2 chemiluminescence system using quinoxaline derivatives as green fluorophores.

  Journal of fluorescence 20100501

• 3-[2-(3-Methyl-quinoxalin-2-yl-oxy)eth-yl]-1,3-oxazolidin-2-one.

  Acta crystallographica. Section E, Structure reports online 20100501

• Identification of phenylsulfone-substituted quinoxaline (WYE-672) as a tissue selective liver X-receptor (LXR) agonist.

  Journal of medicinal chemistry 20100422

• Selective excitatory actions of DNQX and CNQX in rat thalamic neurons.

  Journal of neurophysiology 20100401

• Identification and quantification of the glucose degradation product glucosone in peritoneal dialysis fluids by HPLC/DAD/MSMS.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100401

• 2-Methyl-3-(n-octylsulfan-yl)quinoxaline.

  Acta crystallographica. Section E, Structure reports online 20100401

• Analysis, distribution, and dietary exposure of glyoxal and methylglyoxal in cookies and their relationship with other heat-induced contaminants.

  Journal of agricultural and food chemistry 20100310

• Neuropharmacology of vestibular system disorders.

  Current neuropharmacology 20100301

• Pyridinylquinoxalines and pyridinylpyridopyrazines as lead compounds for novel p38 alpha mitogen-activated protein kinase inhibitors.

  Journal of medicinal chemistry 20100211

• Modulation of carcinogen metabolizing enzymes by new fused heterocycles pendant to 5,6,7,8-tetrahydronaphthalene derivatives.

  European journal of medicinal chemistry 20100201

• Electrochemistry and spectroelectrochemistry of beta,beta'-fused quinoxalinoporphyrins and related extended bis-porphyrins with Co(III), Co(II), and Co(I) central metal ions.

  Inorganic chemistry 20100201

• A validated high-performance liquid chromatography-ultraviolet method for quantification of the CCR5 inhibitor maraviroc in plasma of HIV-infected patients.

  Therapeutic drug monitoring 20100201

• Sodium tetrachloroaurate(III) dihydrate-catalyzed efficient synthesis of 1,5-benzodiazepine and quinoxaline derivatives.

  Journal of Zhejiang University. Science. B 20100201

• 2,2'-(Quinoxaline-2,3-di-yl)diphenol dimethyl-formamide solvate.

  Acta crystallographica. Section E, Structure reports online 20100201

• Efficient and long-time stable red iridium(III) complexes for organic light-emitting diodes based on quinoxaline ligands.

  Inorganic chemistry 20100118

• Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasma.

  Analytical and bioanalytical chemistry 20100101

• Chemistry of secondary polyphenols produced during processing of tea and selected foods.

  International journal of molecular sciences 20100101

• Acute and subchronic toxicological evaluation of Mequindox in Wistar rats.

  Regulatory toxicology and pharmacology : RTP 20100101

• One-pot three-component synthesis of quinoxaline and phenazine ring systems using Fischer carbene complexes.

  Beilstein journal of organic chemistry 20100101

• Synthesis, Characterization, DNA Binding, and Photocleavage Activity of Oxorhenium (V) Complexes with alpha-Diimine and Quinoxaline Ligands.

  Bioinorganic chemistry and applications 20100101

• An oligopeptide transporter of Mycobacterium tuberculosis regulates cytokine release and apoptosis of infected macrophages.

  PloS one 20100101

• Glutamatergic mechanisms for speed control and network operation in the rodent locomotor CpG.

  Frontiers in neural circuits 20100101

• Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition.

  PloS one 20100101

• Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21.

  Radiation oncology (London, England) 20100101

• Metabotropic glutamate receptors: potential drug targets for psychiatric disorders.

  The open medicinal chemistry journal 20100101

• Tetra-μ-benzoato-bis-{[4-(pyrrolidin-1-yl)pyridine]zinc(II)}.

  Acta crystallographica. Section E, Structure reports online 20100101

• 2,3-Bis(4-ethoxy-phen-yl)quinoxaline.

  Acta crystallographica. Section E, Structure reports online 20100101

• Quinoxaline-2-carbonitrile.

  Acta crystallographica. Section E, Structure reports online 20100101

• A ferrocene-quinoxaline derivative as a highly selective probe for colorimetric and redox sensing of toxic mercury(II) cations.

  Sensors (Basel, Switzerland) 20100101

• Tetra-μ-benzoato-bis-{[trans-1-(2-pyrid-yl)-2-(4-pyrid-yl)ethyl-ene]zinc(II)}.

  Acta crystallographica. Section E, Structure reports online 20091201

• 4-[(2,5-Dimethyl-anilino)acet-yl]-3,4-di-hydro-quinoxalin-2(1H)-one.

  Acta crystallographica. Section E, Structure reports online 20091201

• Phenazine-naphthalene-1,5-diamine-water (1/1/2).

  Acta crystallographica. Section E, Structure reports online 20091201

• Profiling of alpha-dicarbonyl content of commercial honeys from different botanical origins: identification of 3,4-dideoxyglucoson-3-ene (3,4-DGE) and related compounds.

  Journal of agricultural and food chemistry 20091125

• Development of novel conjugated donor polymers for high-efficiency bulk-heterojunction photovoltaic devices.

  Accounts of chemical research 20091117

• Synthesis and antibacterial activity of some new heterocycles incorporating phthalazine.

  European journal of medicinal chemistry 20091101

• Synthesis, characterization and derivatization of some novel types of mono- and bis-imidazolidineiminothiones and imidazolidineiminodithiones with antitumor, antiviral, antibacterial and antifungal activities--part I.

  European journal of medicinal chemistry 20091101

• Bis[μ-1-(2-pyridylmeth-yl)-1H-benzo-triazole]disilver(I) bis-(perchlorate).

  Acta crystallographica. Section E, Structure reports online 20091101

• Change in the site of electron-transfer reduction of a zinc-quinoxalinoporphyrin/gold-quinoxalinoporphyrin dyad by binding of scandium ions and the resulting remarkable elongation of the charge-shifted-state lifetime.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20091012

• Investigation of quinocetone-induced genotoxicity in HepG2 cells using the comet assay, cytokinesis-block micronucleus test and RAPD analysis.

  Toxicology in vitro : an international journal published in association with BIBRA 20091001

• 1-Methyl-3-phenyl-quinoxalin-2(1H)-one.

  Acta crystallographica. Section E, Structure reports online 20091001

• Synthesis, characterization and antimicrobial activity of 3d transition metal complexes of a biambidentate ligand containing quinoxaline moiety.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20090915

• catena-Poly[[bis-(2-hydr-oxy-2-phenyl-acetato-κO,O)zinc(II)]-μ-1,2-di-4-pyridylethane-κN:N'].

  Acta crystallographica. Section E, Structure reports online 20090901

• (S)-Ethyl 2-[4-(6-chloro-quinoxalin-2-yl-oxy)phen-oxy]propanoate.

  Acta crystallographica. Section E, Structure reports online 20090901

• Synthesis, characterization and redox chemistry of Ru(II) complexes of N-methyl pyridyl quinoxaline.

  Dalton transactions (Cambridge, England : 2003) 20090821

• Biomonitoring of carcinogenic heterocyclic aromatic amines in hair: a validation study.

  Chemical research in toxicology 20090817

• Cavitands with mobile walls.

  Organic letters 20090806

• Targeted radionuclide therapy of melanoma: anti-tumoural efficacy studies of a new 131I labelled potential agent.

  International journal of cancer 20090801

• Synthesis of novel quinoxaline derivatives and its cytotoxic activities.

  Bioorganic & medicinal chemistry letters 20090801

• N-[(E)-Quinoxalin-2-ylmethyl-idene]-1H-indazol-5-amine.

  Acta crystallographica. Section E, Structure reports online 20090801

• 3-[2-(3-Methyl-2-oxo-1,2-dihydro-quinoxalin-1-yl)eth-yl]oxazolidin-2-one.

  Acta crystallographica. Section E, Structure reports online 20090801

• A fluorescent probe for diacetyl detection.

  Journal of fluorescence 20090701

• Synthesis and evaluation of a novel series of heterocyclic oleanolic acid derivatives with anti-osteoclast formation activity.

  European journal of medicinal chemistry 20090701

• Dichloridobis(phenanthridine-κN)zinc(II).

  Acta crystallographica. Section E, Structure reports online 20090701

• 3-(4-Fluoro-phen-yl)-6-meth-oxy-2-(4-pyrid-yl)quinoxaline.

  Acta crystallographica. Section E, Structure reports online 20090701

• Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs.

  Molecules (Basel, Switzerland) 20090622

• New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090615

• Reactivity of 1-deoxy-D-erythro-hexo-2,3-diulose: a key intermediate in the maillard chemistry of hexoses.

  Journal of agricultural and food chemistry 20090610

• Multiple modes for coordination of phenazine to molybdenum: ring fusion promotes access to eta4-coordination, oxidative addition of dihydrogen and hydrogenation of aromatic nitrogen compounds.

  Journal of the American Chemical Society 20090610

• 2-(3-Aryl-2-propenoyl)-3-methylquinoxaline-1,4-dioxides: a novel cluster of tumor-specific cytotoxins which reverse multidrug resistance.

  Bioorganic & medicinal chemistry 20090601

• Antitumor compounds from marine actinomycetes.

  Marine drugs 20090601

• 4-[3-(4-Fluoro-phen-yl)quinoxalin-2-yl]-N-isopropyl-pyridin-2-amine.

  Acta crystallographica. Section E, Structure reports online 20090601

• Silica bonded S-sulfonic acid: a recyclable catalyst for the synthesis of quinoxalines at room temperature.

  Molecules (Basel, Switzerland) 20090522

• Emission mechanism of doubly ortho-linked quinoxaline/diphenylfluorene or cis-stilbene/fluorene hybrid compounds based on the transient absorption and emission measurements during pulse radiolysis.

  Journal of the American Chemical Society 20090520

• The photophysics of selectively metallated arrays of quinoxaline-fused tetraarylporphyrins.

  Physical chemistry chemical physics : PCCP 20090514

• Theoretical quest for photoconversion molecules having opposite directions of the electric dipole moment in S0 and S1 states.

  The Journal of chemical physics 20090514

• Review of the occurrence of anti-infectives in contaminated wastewaters and natural and drinking waters.

  Environmental health perspectives 20090501

• Fluorescence control on panchromatic spectra via c-alkylation on arylated quinoxalines.

  The Journal of organic chemistry 20090417

• S(N)(H) approach in the synthesis of nitronyl nitroxides.

  The Journal of organic chemistry 20090403

• Synthesis and in vitro antitumor activity of new quinoxaline derivatives.

  European journal of medicinal chemistry 20090401

• Aqua-dinitrato(quioxalino[2,3-f][1,10]phenanthroline)nickel(II) monohydrate.

  Acta crystallographica. Section E, Structure reports online 20090401

• 1-Naphthyl quinoxalin-2-yl ether.

  Acta crystallographica. Section E, Structure reports online 20090401

• 2-Naphthyl quinoxalin-2-yl ether.

  Acta crystallographica. Section E, Structure reports online 20090401

• The chemotherapeutic agents XK469 (2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid) and SH80 (2-{4-[(7-bromo-2-quinolinyl)oxy]phenoxy}propionic acid) inhibit cytokinesis and promote polyploidy and induce senescence.

  The Journal of pharmacology and experimental therapeutics 20090301

• TioS T-TE--a prototypical thioesterase responsible for cyclodimerization of the quinoline- and quinoxaline-type class of chromodepsipeptides.

  The FEBS journal 20090301

• Ethanol Does Not Promote MeIQx-initiated Rat Colon Carcinogenesis Based on Evidence from Analysis of a Colon Cancer Surrogate Marker.

  Journal of toxicologic pathology 20090301

• Cytotoxic palladium complexes of bioreductive quinoxaline N1,N4-dioxide prodrugs.

  Bioorganic & medicinal chemistry 20090215

• DNA binding and oxidative DNA cleavage activity of (mu-oxo)diiron(iii) complexes in visible light.

  Dalton transactions (Cambridge, England : 2003) 20090214

• Simultaneous quantification of linezolid, rifampicin, levofloxacin, and moxifloxacin in human plasma using high-performance liquid chromatography with UV.

  Therapeutic drug monitoring 20090201

• N,N'-Bis[(E)-quinoxalin-2-ylmethyl-idene]-ethane-1,2-diamine.

  Acta crystallographica. Section E, Structure reports online 20090201

• Discovery of a novel series of quinoxalines as inhibitors of c-Met kinase.

  Bioorganic & medicinal chemistry letters 20090115

• Stable and highly persistent quinoxaline-centered metalloorganic radical anions: preparation, structural, spectroscopic, and computational investigations.

  Inorganic chemistry 20090105

• Anaerobic photocleavage of DNA in red light by dicopper(II) complexes of 3,3'-dithiodipropionic acid.

  Inorganic chemistry 20090105

• Direct zincation of functionalized aromatics and heterocycles by using a magnesium base in the presence of ZnCl2.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20090101

• Selective activity against Mycobacteriumtuberculosis of new quinoxaline 1,4-di-N-oxides.

  Bioorganic & medicinal chemistry 20090101

• Role of a novel PH-kinase domain interface in PKB/Akt regulation: structural mechanism for allosteric inhibition.

  PLoS biology 20090101

• The radiosensitizer 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide induces DNA damage in EMT-6 mammary carcinoma cells.

  Radiation oncology (London, England) 20090101

• QSAR modeling for quinoxaline derivatives using genetic algorithm and simulated annealing based feature selection.

  Current medicinal chemistry 20090101

• RT-SHIV subpopulation dynamics in infected macaques during anti-HIV therapy.

  Retrovirology 20090101

• Phylogenetics of an antibiotic producing Streptomyces strain isolated from soil.

  Bioinformation 20090101

• DNA oxidative cleavage induced by the novel peptide derivatives of 3-(quinoxalin-6-yl)alanine in combination with Cu(II) or Fe(II) ions.

  Bioinorganic chemistry and applications 20090101

• N-(Quinoxalin-2-yl)-4-toluidine.

  Acta crystallographica. Section E, Structure reports online 20090101

• 3,5-Dichloro-6-methyl-pyridin-2-amine.

  Acta crystallographica. Section E, Structure reports online 20090101

• Turning on fluorescent emission from C-alkylation on quinoxaline derivatives.

  Organic letters 20081204

• An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patients.

  Therapeutic drug monitoring 20081201

• Chemical substructures that enrich for biological activity.

  Bioinformatics (Oxford, England) 20081101

• 1-Ethyl-3-methyl-quinoxalin-2(1H)-one.

  Acta crystallographica. Section E, Structure reports online 20081101

• Cu(II)-mediated synthesis of a new fluorescent pyrido[1,2-a]quinoxalin-11-ium derivative.

  Inorganic chemistry 20081020

• Potassium t-butoxide alone can promote the biaryl coupling of electron-deficient nitrogen heterocycles and haloarenes.

  Organic letters 20081016

• Synthesis of new pyrrolo[1,2-a]quinoxaline derivatives as potential inhibitors of Akt kinase.

  Journal of enzyme inhibition and medicinal chemistry 20081001

• A mixed-valence copper coordination polymer generated by a hydrothermal metal/ligand redox reaction process.

  Acta crystallographica. Section C, Crystal structure communications 20081001

• 1,2,3-Triphenyl-1,2-dihydro-quinoxaline.

  Acta crystallographica. Section E, Structure reports online 20081001

• In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide.

  The Journal of antimicrobial chemotherapy 20080901

• Tetra-μ-benzoato-bis-[(3-methyl-quinoline)copper(II)](Cu-Cu).

  Acta crystallographica. Section E, Structure reports online 20080901

• 2-(7,8-Diphenyl-1H-imidazo[4,5-f]quinoxalin-2-yl)phenol methanol disolvate.

  Acta crystallographica. Section E, Structure reports online 20080901

• Phenyl quinoxalin-2-yl ether.

  Acta crystallographica. Section E, Structure reports online 20080901

• Enzymatic macrolactonization in the presence of DNA leading to triostin A analogs.

  Chemistry & biology 20080825

• Chemical stability and reactivity of deprotonated oligonucleotides (DNA) in the gas phase: protonation and solvation with hydrogen bromide.

  The journal of physical chemistry. B 20080821

• Syntheses and evaluation of 3-(3-bromo phenyl)-5-phenyl-1-(thiazolo [4,5-b] quinoxaline-2-yl)-2-pyrazoline derivatives.

  European journal of medicinal chemistry 20080801

• On application of constitutional descriptors for merging of quinoxaline data sets using linear statistical methods.

  Chemical biology & drug design 20080801

• A phase I and pharmacokinetic study of the quinoxaline antitumour Agent R(+)XK469 in patients with advanced solid tumours.

  European journal of cancer (Oxford, England : 1990) 20080801

• 2-[(E)-(5-Amino-2,3-diphenyl-quinoxalin-6-yl)imino-meth-yl]-4-chloro-phenol.

  Acta crystallographica. Section E, Structure reports online 20080801

• DNA binding by analogues of the bifunctional intercalator TANDEM.

  Biochemistry 20080729

• Androgynous porphyrins. Silver(II) quinoxalinoporphyrins act as both good electron donors and acceptors.

  Journal of the American Chemical Society 20080723

• Toward prediction of alkane/water partition coefficients.

  Journal of medicinal chemistry 20080710

• Tetra-μ-benzoato-bis-[(6-methyl-quino-line)-copper(II)].

  Acta crystallographica. Section E, Structure reports online 20080701

• rac-(4aR,8aR)-2,3-Diphenyl-4a,5,6,7,8,8a-hexa-hydro-quinoxaline.

  Acta crystallographica. Section E, Structure reports online 20080701

• rac-(2R,3S)-2-Phenyl-3-(3-phenyl-1,2,3,4-tetra-hydro-quinoxalin-2-yl)quinoxaline.

  Acta crystallographica. Section E, Structure reports online 20080701

• 2-[(E)-(5-Amino-2,3-diphenyl-quinoxalin-6-yl)imino-meth-yl]-4-bromo-phenol.

  Acta crystallographica. Section E, Structure reports online 20080701

• Allosteric inhibitors of Akt1 and Akt2: a naphthyridinone with efficacy in an A2780 tumor xenograft model.

  Bioorganic & medicinal chemistry letters 20080601

• Cholic acid-quinoxaline (2/1).

  Acta crystallographica. Section E, Structure reports online 20080601

• Nicotine-activated descending facilitation on spinal NMDA-dependent reflex potentiation from pontine tegmentum in rats.

  American journal of physiology. Renal physiology 20080501

• Quinoxaline-3-amino-phenol-water (2/1/2).

  Acta crystallographica. Section E, Structure reports online 20080501

• Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand.

  Molecular nutrition & food research 20080401

• Metabolism of olaquindox in rat liver microsomes: structural elucidation of metabolites by high-performance liquid chromatography combined with ion trap/time-of-flight mass spectrometry.

  Rapid communications in mass spectrometry : RCM 20080401

• Preferred binding sites for the bifunctional intercalator TANDEM determined using DNA fragments that contain every symmetrical hexanucleotide sequence.

  Analytical biochemistry 20080315

• Q39, a novel synthetic Quinoxaline 1,4-Di-N-oxide compound with anti-cancer activity in hypoxia.

  European journal of pharmacology 20080310

• Regiospecific beta-functionalization of free-base porphyrins by pseudohalogens.

  Organic & biomolecular chemistry 20080307

• 1,4-Dihydroxy-quinoxaline-2,3(1H,4H)-dione.

  Acta crystallographica. Section E, Structure reports online 20080301

• New modes for coordination of aromatic heterocyclic nitrogen compounds to molybdenum: catalytic hydrogenation of quinoline, isoquinoline, and quinoxaline by Mo(PMe3)4H4.

  Journal of the American Chemical Society 20080206

• Characterization of carbadox-induced mutagenesis using a shuttle vector pSP189 in mammalian cells.

  Mutation research 20080201

• New acyclic quinoxaline nucleosides. Synthesis and anti-hiv activity.

  Nucleosides, nucleotides & nucleic acids 20080201

• Tetra-μ-benzoato-bis-[(quinoxaline)copper(II)].

  Acta crystallographica. Section E, Structure reports online 20080201

• (4aR,8aR)-2,3-Diphenyl-4a,5,6,7,8,8a-hexa-hydro-quinoxaline.

  Acta crystallographica. Section E, Structure reports online 20080201

• Control of the site and potential of reduction and oxidation processes in pi-expanded quinoxalinoporphyrins.

  Physical chemistry chemical physics : PCCP 20080128

• Control of the orbital delocalization and implications for molecular rectification in the radical anions of porphyrins with coplanar 90 degrees and 180 degrees beta,beta'-fused extensions.

  The journal of physical chemistry. A 20080124

• Substitutions of fluorine atoms and phenoxy groups in the synthesis of quinoxaline 1,4-di-N-oxide derivatives.

  Molecules (Basel, Switzerland) 20080118

• Unexpected reduction of ethyl 3-phenylquinoxaline-2- carboxylate 1,4-di-N-oxide derivatives by amines.

  Molecules (Basel, Switzerland) 20080117

• Control of the site and potential of reduction and oxidation processes in pi-expanded quinoxalinoporphyrins.

  Physical chemistry chemical physics : PCCP 20080114

• Antiplasmodial structure-activity relationship of 3-trifluoromethyl-2-arylcarbonylquinoxaline 1,4-di-N-oxide derivatives.

  Experimental parasitology 20080101

• Synthesis, characterization, DFT studies and DNA binding of mixed platinum (II) complexes containing quinoxaline and 1,2-dithiolate ligands.

  Journal of inorganic biochemistry 20080101

• Improved production of triostin A in engineered Escherichia coli with furnished quinoxaline chromophore by design of experiments in small-scale culture.

  Biotechnology progress 20080101

• Green and efficient synthesis of quinoxaline derivatives via ceric ammonium nitrate promoted and in situ aerobic oxidation of alpha-hydroxy ketones and alpha-keto oximes in aqueous media.

  Chemical & pharmaceutical bulletin 20080101

• Application of oligonucleotide microarray technology to toxic occupational exposures.

  Journal of toxicology and environmental health. Part A 20080101

• Electrospray tandem mass spectrometric analysis of novel synthetic quinoxalinone derivatives.

  Rapid communications in mass spectrometry : RCM 20080101

• Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum.

  BMC infectious diseases 20080101

• Poly[bis-(μ(2)-formato-κO:O')(quinoxaline-κN)copper(II)].

  Acta crystallographica. Section E, Structure reports online 20080101

• 2,2,3,3'-Tetra-phenyl-7,7'-biquinoxaline.

  Acta crystallographica. Section E, Structure reports online 20080101

• 2,3-Bis(4-bromo-phen-yl)quinoxaline.

  Acta crystallographica. Section E, Structure reports online 20080101

• Effect of axial ligands and macrocyclic structure on redox potentials and electron-transfer mechanisms of SnIV porphyrins.

  Inorganic chemistry 20071210

• HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20071115

• Synthesis and biological evaluation of new 2-arylcarbonyl-3-trifluoromethylquinoxaline 1,4-di-N-oxide derivatives and their reduced analogues.

  Journal of medicinal chemistry 20071101

• Isolation and determination of alpha-dicarbonyl compounds by RP-HPLC-DAD in green and roasted coffee.

  Journal of agricultural and food chemistry 20071031

• Copper(I) cyanide networks: synthesis, luminescence behavior and thermal analysis. Part 1. Diimine ligands.

  Inorganic chemistry 20071015

• Descending facilitation of spinal NMDA-dependent reflex potentiation from pontine tegmentum in rats.

  American journal of physiology. Renal physiology 20071001

• Electron-deficient N-heteroaromatic linkers for the elaboration of large, soluble polycyclic aromatic hydrocarbons and their use in the synthesis of some very large transition metal complexes.

  Journal of the American Chemical Society 20070926

• An HPLC method for the simultaneous determination of neurotoxic dipyridyl isomers in human plasma.

  Journal of pharmaceutical and biomedical analysis 20070921

• Lithium-mediated zincation of pyrazine, pyridazine, pyrimidine, and quinoxaline.

  The Journal of organic chemistry 20070817

• Quinoxalino[2,3-b']porphyrins behave as pi-expanded porphyrins upon one-electron reduction: broad control of the degree of delocalization through substitution at the macrocycle periphery.

  The journal of physical chemistry. B 20070802

• Validation of an ion-pair liquid chromatography-electrospray-tandem mass spectrometry method for the determination of heterocyclic aromatic amines in meat-based infant foods.

  Food additives and contaminants 20070801

• A quinoxaline 1,4-di-N-oxide derivative induces DNA oxidative damage not attenuated by vitamin C and E treatment.

  Chemico-biological interactions 20070630

• Synthesis and biological evaluation of 4(5)-(6-alkylpyridin-2-yl)imidazoles as transforming growth factor-beta type 1 receptor kinase inhibitors.

  Journal of medicinal chemistry 20070628

• Development of a quantitative method for the analysis of total L-ascorbic acid in foods by high-performance liquid chromatography.

  Journal of chromatography. A 20070622

• Applications of counter-current chromatography in organic synthesis purification of heterocyclic derivatives of lapachol.

  Journal of chromatography. A 20070601

• Simultaneous determination of ketoacids and dicarbonyl compounds, key Maillard intermediates on the generation of aged wine aroma.

  Journal of food science 20070601

• Solvation dynamics and electric field relaxation in an imidazolium-PF6 ionic liquid: from room temperature to the glass transition.

  The journal of physical chemistry. B 20070510

• trans-Bis(dimethyl sulfoxide-kappaO)bis(3-oxo-3,4-dihydroquinoxaline-2-carboxylato-kappa2N1,O2)copper(II).

  Acta crystallographica. Section C, Crystal structure communications 20070501

• A simple and sensitive assay for determining plasma tipranavir concentration in the clinical setting by new HPLC method.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070401

• A phase 1 trial of XK469: toxicity profile of a selective topoisomerase IIbeta inhibitor.

  Investigational new drugs 20070401

• Structure-activity relationship (SAR) studies of quinoxalines as novel HCV NS5B RNA-dependent RNA polymerase inhibitors.

  Bioorganic & medicinal chemistry letters 20070315

• Biosynthesis of thiamin thiazole in eukaryotes: conversion of NAD to an advanced intermediate.

  Journal of the American Chemical Society 20070314

• Competitive AMPA receptor antagonists.

  Medicinal research reviews 20070301

• An efficient synthesis of quinoxaline derivatives from 4-chloro-4-deoxy-alpha-D-galactose and their cytotoxic activities.

  Bioorganic & medicinal chemistry letters 20070201

• Quinoxaline-imidazolium receptors for unique sensing of pyrophosphate and acetate by charge transfer.

  Organic letters 20070201

• Characterization of benzimidazole and other oxidative and conjugative metabolites of brimonidine in vitro and in rats in vivo using on-line HID exchange LC-MS/MS and stable-isotope tracer techniques.

  Xenobiotica; the fate of foreign compounds in biological systems 20070201

• Radiosensitization by 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide under oxia and hypoxia in human colon cancer cells.

  Radiation oncology (London, England) 20070101

• Accurate reproduction of 161 small-molecule complex crystal structures using the EUDOC program: expanding the use of EUDOC to supramolecular chemistry.

  PloS one 20070101

• Comparative acute systemic toxicity of several quinoxaline 1,4-di-N-oxides in Wistar rats.

  Arzneimittel-Forschung 20070101

• A theoretical study of a family of new quinoxaline derivatives.

  Journal of molecular graphics & modelling 20061201

• Reaction kinetics and transformation of carbadox and structurally related compounds with aqueous chlorine.

  Environmental science & technology 20061201

• New quinoxaline 1,4-di-N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1,4-di-N-oxides.

  Bioorganic & medicinal chemistry 20061015

• One novel quinoxaline derivative as a potent human cyclophilin A inhibitor shows highly inhibitory activity against mouse spleen cell proliferation.

  Bioorganic & medicinal chemistry 20060815

• Improving anti-trypanosomal activity of 3-aminoquinoxaline-2-carbonitrile N1,N4-dioxide derivatives by complexation with vanadium.

  Bioorganic & medicinal chemistry 20060815

• Molecular mechanism of mutagenesis induced by olaquindox using a shuttle vector pSP189/mammalian cell system.

  Mutation research 20060725

• A new efficient route for the formation of quinoxaline N-oxides and N,N'-dioxides using HOF.CH3CN.

  The Journal of organic chemistry 20060721

• Solvent response and dielectric relaxation in supercooled butyronitrile.

  The Journal of chemical physics 20060714

• Does the donor-acceptor concept work for designing synthetic metals? III. Theoretical investigation of copolymers between quinoid acceptors and aromatic donors.

  Journal of molecular modeling 20060701

• Conformational behavior of pyrazine-bridged and mixed-bridged cavitands: a general model for solvent effects on thermal 'vase-kite' switching.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20060614

• Synthesis, a case of isostructural packing, and antimicrobial activity of silver(I)quinoxaline nitrate, silver(I)(2,5-dimethylpyrazine) nitrate and two related silver aminopyridine compounds.

  Dalton transactions (Cambridge, England : 2003) 20060607

• Synthesis, characterization and antiamoebic activity of 1-(thiazolo[4,5-b]quinoxaline-2-yl)-3-phenyl-2-pyrazoline derivatives.

  Bioorganic & medicinal chemistry letters 20060515

• [Simultaneous determination of twelve glucocorticoids residues in milk by ultra performance liquid chromatography-electrospray tandem mass spectrometry].

  Se pu = Chinese journal of chromatography 20060501

• New manganese-scaffolded organic triple-deckers based on quinoxaline, pyrazine and pyrimidine cores.

  Dalton transactions (Cambridge, England : 2003) 20060328

• Encapsulation of metal cations and anions within the cavity of bis(1,4,7-triazacyclononane) receptors.

  Dalton transactions (Cambridge, England : 2003) 20060321

• Spin-lattice relaxation and rotational motion of aromatic triplet-state molecules in supercooled alkane solvents (part 1).

  The journal of physical chemistry. A 20060309

• Dynamics of a supercooled ionic liquid studied by optical and dielectric spectroscopy.

  The journal of physical chemistry. B 20060309

• Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling.

  Bioorganic & medicinal chemistry 20060301

• Synthesis of variously substituted 3-phenoxymethyl quinoxalin-2-ones and quinoxalines capable to potentiate in vitro the antiproliferative activity of anticancer drugs in multi-drug resistant cell lines.

  Medicinal chemistry (Shariqah (United Arab Emirates)) 20060301

• Synthesis and antiprotozoal activity of some new synthetic substituted quinoxalines.

  Bioorganic & medicinal chemistry letters 20060215

• Detection of dideoxyosone intermediates of glycation using a monoclonal antibody: characterization of major epitope structures.

  Archives of biochemistry and biophysics 20060215

• Quantitative structure-activity relationships for small non-peptide antagonists of CXCR2: indirect 3D approach using the frontal polygon method.

  Bioorganic & medicinal chemistry 20060115

• Recent advances in the solid-phase combinatorial synthetic strategies for the quinoxaline, quinazoline and benzimidazole based privileged structures.

  Mini reviews in medicinal chemistry 20060101

• [Echinomycin production by Actinomadura sp. INA 654].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20060101

• Scope and mechanistic study of the ruthenium-catalyzed ortho-C-H bond activation and cyclization reactions of arylamines with terminal alkynes.

  Journal of the American Chemical Society 20051207

• Selective steroid recognition by a partially bridged resorcin[4]arene cavitand.

  Chemical communications (Cambridge, England) 20051114

• Synthesis and luminescence properties of U-shaped polycyclic molecules containing syn-facial functionalized quinoxaline rings.

  Organic letters 20051027

• Investigation of the separation of heterocyclic aromatic amines by reversed phase ion-pair liquid chromatography coupled with tandem mass spectrometry: the role of ion pair reagents on LC-MS/MS sensitivity.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20051025

• Novel cyclophilin D inhibitors derived from quinoxaline exhibit highly inhibitory activity against rat mitochondrial swelling and Ca2+ uptake/ release.

  Acta pharmacologica Sinica 20051001

• Efficient solid-phase-based total synthesis of the bisintercalator TANDEM.

  The Journal of organic chemistry 20050916

• [Design and synthesis of quinoxaline derivatives and their antitumor activities].

  Yao xue xue bao = Acta pharmaceutica Sinica 20050901

• Synthesis of 1,3,4-thiadiazole, 1,3,4-thiadiazine, 1,3,6-thiadiazepane and quinoxaline derivatives from symmetrical dithiobiureas and thioureidoethylthiourea derivatives.

  Molecules (Basel, Switzerland) 20050831

• Proton driven vase-to-kite conformational change in cavitands at an air-water interface monitored by surface SHG.

  Langmuir : the ACS journal of surfaces and colloids 20050802

• Synthesis of selective SRPK-1 inhibitors: novel tricyclic quinoxaline derivatives.

  Bioorganic & medicinal chemistry letters 20050701

• Prediction of genotoxicity of chemical compounds by statistical learning methods.

  Chemical research in toxicology 20050601

• DNA damage induced by a quinoxaline 1,4-di-N-oxide derivative (hypoxic selective agent) in Caco-2 cells evaluated by the comet assay.

  Mutagenesis 20050501

• Quinoxaline 1,4-dioxides induce G2/M cell cycle arrest and apoptosis in human colon cancer cells.

  Cancer chemotherapy and pharmacology 20050401

• Synthesis and characterization of p-phenylenediamine derivatives bearing an electron-acceptor unit.

  The Journal of organic chemistry 20050401

• Replacement of active-site residues of quinoline 2-oxidoreductase involved in substrate recognition and specificity.

  Current microbiology 20050401

• Iridium(III) complexes with orthometalated quinoxaline ligands: subtle tuning of emission to the saturated red color.

  Inorganic chemistry 20050307

• Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP-ribose) polymerase-1/2 inhibitors.

  FEBS letters 20050227

• Part 3: synthesis and biological evaluation of some analogs of the antitumor agents, 2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid, and 2-{4-[(7-bromo-2-quinolinyl)oxy]phenoxy}propionic acid.

  Bioorganic & medicinal chemistry 20050215

• Functional cross-talk between fatty acid synthesis and nonribosomal peptide synthesis in quinoxaline antibiotic-producing streptomycetes.

  The Journal of biological chemistry 20050211

• Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties.

  Journal of medicinal chemistry 20050210

• Water-soluble benzoheterocycle triosmium clusters as potential inhibitors of telomerase enzyme.

  Journal of inorganic biochemistry 20050201

• In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria.

  International journal of antimicrobial agents 20050201

• On the microscopic theory of polar solvation dynamics.

  The Journal of chemical physics 20050122

• Reactivity and transformation of antibacterial N-oxides in the presence of manganese oxide.

  Environmental science & technology 20050115

• [Studying the efficacy of a series of quinoxaline and azolo[a(b)]quinoxaline derivatives as P2X receptor antagonists].

  Eksperimental'naia i klinicheskaia farmakologiia 20050101

• Selective toxicity of a quinoxaline 1,4-di-N-oxide derivative in human tumour cell lines.

  Arzneimittel-Forschung 20050101

• Quinoxaline 1,4-dioxide: a versatile scaffold endowed with manifold activities.

  Current medicinal chemistry 20050101

• Topical administration of Caroverine in somatic tinnitus treatment: proof-of-concept study.

  The international tinnitus journal 20050101

• Synthesis and pharmacological evaluation of novel quinoxalines as potential nonulcerogenic anti-inflammatory and analgesic agents.

  Arzneimittel-Forschung 20050101

• Synthesis and antimalarial activity of new 3-arylquinoxaline-2-carbonitrile derivatives.

  Arzneimittel-Forschung 20050101

• Re-establishment of olfactory and taste functions.

  GMS current topics in otorhinolaryngology, head and neck surgery 20050101

• Immunochemical detection of 3-deoxyglucosone in serum.

  Biochemical and biophysical research communications 20041217

• Lewis acid-promoted annulation of O-quinonediimines by allylstannane: a facile synthesis of quinoxaline derivatives.

  Organic letters 20041209

• Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries.

  Cardiovascular research 20041001

• A new family of quinoline and quinoxaline analogues of combretastatins.

  Bioorganic & medicinal chemistry letters 20040716

• Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivatives.

  Bioorganic & medicinal chemistry 20040701

• Occurrence of antimicrobials in the final effluents of wastewater treatment plants in Canada.

  Environmental science & technology 20040701

• Zn(II)-induced conformational control of amphiphilic cavitands in langmuir monolayers.

  Chemical communications (Cambridge, England) 20040621

• Solution-phase synthesis of nucleobase-substituted analogues of triostin A.

  The Journal of organic chemistry 20040528

• Lead discovery of quinoxalinediones as an inhibitor of dipeptidyl peptidase-IV (DPP-IV) by high-throughput screening.

  Bioorganic & medicinal chemistry letters 20040517

• Co-targeting IGF-1R and c-kit: synergistic inhibition of proliferation and induction of apoptosis in H 209 small cell lung cancer cells.

  British journal of cancer 20040504

• Quinoxaline 1,4-dioxides are novel angiogenesis inhibitors that potentiate antitumor effects of ionizing radiation.

  International journal of oncology 20040501

• Thermodynamic properties of quinoxaline-1,4-dioxide derivatives: a combined experimental and computational study.

  The Journal of organic chemistry 20040416

• [How have we found any new reactions in the field of the heterocyclic chemistry?].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20040401

• Design and synthesis of novel imidazo[1,2-a]quinoxalines as PDE4 inhibitors.

  Bioorganic & medicinal chemistry 20040301

• Quinoxaline chemistry. Part XVII. Methyl [4-(substituted 2-quinoxalinyloxy) phenyl] acetates and ethyl N-([4-(substituted 2-quinoxalinyloxy) phenyl] acetyl) glutamates analogs of methotrexate: synthesis and evaluation of in vitro anticancer activity.

  Farmaco (Societa chimica italiana : 1989) 20040301

• Successive determination of thiamine and ascorbic acid in pharmaceuticals by flow injection analysis.

  Journal of pharmaceutical and biomedical analysis 20040218

• Quinoxaline excision: a novel approach to tri- and diquinoxaline cavitands.

  Organic letters 20040205

• Metal-assisted light-induced DNA cleavage activity of 2-(methylthio)phenylsalicylaldimine Schiff base copper(II) complexes having planar heterocyclic bases.

  Journal of inorganic biochemistry 20040201

• Synthesis and Bergman cyclization of a beta-extended porphyrenediyne.

  Chemical communications (Cambridge, England) 20040121

• Synthesis and biological activity of new quinoxaline antibiotics of echinomycin analogues.

  Bioorganic & medicinal chemistry letters 20040119

• The influence of intercalator binding on DNA triplex stability: correlation with effects on A-tract duplex structure.

  Journal of molecular recognition : JMR 20040101

• The effect of oxythioquinox exposure on normal human mammary epithelial cell gene expression: a microarray analysis study.

  Environmental health : a global access science source 20040101

• [New methyl-quinoxaline derivatives with antimicrobial activity].

  Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20040101

• Photophysical processes in quinoxaline vapor at low pressure.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20031101

• Coordination properties of new bis(1,4,7-triazacyclononane) ligands: a highly active dizinc complex in phosphate diester hydrolysis.

  Inorganic chemistry 20031020

• Alternative pathway for the formation of 4,5-dihydroxy-2,3-pentanedione, the proposed precursor of 4-hydroxy-5-methyl-3(2H)-furanone as well as autoinducer-2, and its detection as natural constituent of tomato fruit.

  Biochimica et biophysica acta 20031013

• Metal-assisted red light-induced efficient DNA cleavage by dipyridoquinoxaline-copper(II) complex.

  Chemical communications (Cambridge, England) 20031007

• 5,8-dimethoxy-2,3-bis(2-pyridyl)quinoxaline.

  Acta crystallographica. Section C, Crystal structure communications 20030901

• Quinoxaline chemistry. Part 16. 4-substituted anilino and 4-substituted phenoxymethyl pyrrolo[1,2-a]quinoxalines and N-[4-(pyrrolo[1,2-a]quinoxalin-4-yl)amino and hydroxymethyl]benzoyl glutamates. Synthesis and evaluation of in vitro biological activity.

  Farmaco (Societa chimica italiana : 1989) 20030901

• Validation of a sensitive assay for thiocoraline in mouse plasma using liquid chromatography-tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030825

• Synthesis and physical properties of biquinoxalinyl bridged bis-porphyrins: models for aspects of photosynthetic reaction centres.

  Organic & biomolecular chemistry 20030807

• Kakadumycins, novel antibiotics from Streptomyces sp NRRL 30566, an endophyte of Grevillea pteridifolia.

  FEMS microbiology letters 20030729

• Identification of a quinoxaline derivative that is a potent telomerase inhibitor leading to cellular senescence of human cancer cells.

  The Biochemical journal 20030715

• DNA sequence specificity for topoisomerase II poisoning by the quinoxaline anticancer drugs XK469 and CQS.

  Molecular pharmacology 20030601

• Synthesis of 5,12-dioxocyclam nickel (II) complexes having quinoxaline substituents at the 6 and 13 positions as potential DNA bis-intercalating and cleaving agents.

  The Journal of organic chemistry 20030530

• Photochemical and photobiological studies of tirapazamine (SR 4233) and related quinoxaline 1,4-Di-N-oxide analogues.

  Chemical research in toxicology 20030201

• DNA interactions of new mixed-ligand complexes of cobalt(III) and nickel(II) that incorporate modified phenanthroline ligands.

  Journal of inorganic biochemistry 20030201

• Dynamic pelvic-pudendal reflex plasticity mediated by glutamate in anesthetized rats.

  Neuropharmacology 20030201

• Metal complexes with 2,3-bis(diphenylphosphino)-1,4-diazadiene ligands: synthesis, structures, and an intramolecular metal-mediated [4 + 2] cycloaddition employing a benzene ring as a dienophile.

  Inorganic chemistry 20030127

• Quinoxaline chemistry. Part 15. 4-[2-Quinoxalylmethylenimino]-benzoylglutamates and -benzoates, 4-[2-quinoxalylmethyl-N-methylamino]-benzoylglutamates as analogues of classical antifolate agents. Synthesis, elucidation of structures and in vitro evaluation of antifolate and anticancer activities.

  Farmaco (Societa chimica italiana : 1989) 20030101

• Site-specific quantitative evaluation of the protein glycation product N6-(2,3-dihydroxy-5,6-dioxohexyl)-L-lysinate by LC-(ESI)MS peptide mapping: evidence for its key role in AGE formation.

  Bioconjugate chemistry 20030101

• Synthesis and antimycobacterial activity of pyrazine and quinoxaline derivatives.

  Journal of medicinal chemistry 20021205

• The quinoxaline derivative caroverine in the treatment of sensorineural smell disorders: a proof-of-concept study.

  Acta oto-laryngologica 20021201

• Hybrid coordination polymer constructed from beta-octamolybdates linked by quinoxaline and its oxidized product benzimidazole coordinated to binuclear copper(I) fragments.

  Inorganic chemistry 20021104

• Synthesis and antibacterial activity of fused 1, 2, 4-triazolo[4, 3-a]quinoxaline and oxopyrimido[2', 1':5, 1]-1, 2, 4-triazolo[4, 3-a]quinoxaline derivatives.

  Archiv der Pharmazie 20020801

• II. Synthesis and biological evaluation of some bioisosteres and congeners of the antitumor agent, 2-(4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy)propionic acid (XK469).

  Journal of medicinal chemistry 20020704

• Simple and selective spectrophotometric determination of ruthenium after solid phase extraction with some quinoxaline dyes into microcrystalline p-dichlorobenzene.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20020701

• Synthesis of zwitterionic compounds: fully saturated pyrimidinylium and 1,3-diazepinylium derivatives via the novel rearrangement of 3-oxobutanoic acid thioanilide derivatives.

  The Journal of organic chemistry 20020628

• Novel substituted quinoxaline 1,4-dioxides with in vitro antimycobacterial and anticandida activity.

  European journal of medicinal chemistry 20020501

• Quinoxaline-oligopyrroles: improved pyrrole-based anion receptors.

  Chemical communications (Cambridge, England) 20020421

• Quinoxaline 1,4-dioxides: hypoxia-selective therapeutic agents.

  Molecular carcinogenesis 20020401

• Molecular design and evaluation of quinoxaline-carbohydrate hybrids as novel and efficient photo-induced GG-selective DNA cleaving agents.

  Chemical communications (Cambridge, England) 20020207

• Rational determination of transfer free energies of small drugs across the water-oil interface.

  Journal of medicinal chemistry 20020103

• Anti-Mycobacterium tuberculosis agents derived from quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide.

  Arzneimittel-Forschung 20020101

• Clinical experience with caroverine in inner ear diseases.

  Advances in oto-rhino-laryngology 20020101

• Different action of memantine and caroverine on glutamatergic transmission in the mammalian cochlea.

  Advances in oto-rhino-laryngology 20020101

• Quinoxaline chemistry. Part 14. 4-(2-Quinoxalylamino)-phenylacetates and 4-(2-quinoxalylamino)-phenylacetyl-L-glutamates as analogues--homologues of classical antifolate agents. Synthesis and evaluation of in vitro anticancer activity.

  Farmaco (Societa chimica italiana : 1989) 20020101

• Cellular drug action profile paradigm applied to XK469.

  Journal of experimental therapeutics & oncology 20020101

• Comparative study of isoflavone, quinoxaline and oxindole families of anti-angiogenic agents.

  Angiogenesis 20020101

• Synthesis of some new azoles and azines and their condensed derivatives.

  Bollettino chimico farmaceutico 20020101

• Hypoxic cells in tumors as a target for cancer therapy.

  Le Journal medical libanais. The Lebanese medical journal 20020101

• Specific distribution of sialic acids in animal tissues as examined by LC-ESI-MS after derivatization with 1,2-diamino-4,5-methylenedioxybenzene.

  Analytical chemistry 20011115

• New developments in anti-HIV chemotherapy.

  Current medicinal chemistry 20011101

• CNQX increases GABA-mediated synaptic transmission in the cerebellum by an AMPA/kainate receptor-independent mechanism.

  Neuropharmacology 20011101

• Stereochemistry of quinoxaline antagonist binding to a glutamate receptor investigated by Fourier transform infrared spectroscopy.

  The Journal of biological chemistry 20011012

• Redox-activated, hypoxia-selective DNA cleavage by quinoxaline 1,4-di-N-oxide.

  Bioorganic & medicinal chemistry 20010901

• Fluorimetric determination of total ascorbic acid by a stopped-flow mixing technique.

  The Analyst 20010801

• A series of three (E)-2-alkylidene-1,4-di-p-tosyl-1,2,3,4-tetrahydroquinoxaline compounds.

  Acta crystallographica. Section C, Crystal structure communications 20010701

• Preferred binding sites for [N-MeCYs(3), N-MeCys(7)]TANDEM determined using a universal footprinting substrate.

  Analytical biochemistry 20010615

• [Formations and reactions of aromatic furazan compounds].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20010601

• Design, synthesis, and biological evaluation of analogues of the antitumor agent, 2-(4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy)propionic acid (XK469).

  Journal of medicinal chemistry 20010524

• Structural characterization of quinoxaline homopolymers and quinoxaline/ether sulfone copolymers by matrix-assisted laser desorption ionization mass spectrometry.

  Analytical chemistry 20010501

• Mutations in the non-nucleoside binding-pocket interfere with the multi-nucleoside resistance phenotype.

  AIDS (London, England) 20010330

• Formation of a defluorinated metabolite of a quinoxaline antiviral drug catalysed by human cytochrome P450 1A2.

  The Journal of pharmacy and pharmacology 20010301

• Imidazo[1,2-a]quinoxalines: synthesis and cyclic nucleotide phosphodiesterase inhibitory activity.

  European journal of medicinal chemistry 20010301

• Radical and non-radical mechanisms for alkane oxidations by hydrogen peroxide-trifluoroacetic acid.

  The Journal of organic chemistry 20010209

• Inflammation contributes to the postponed ischemic neuronal damage following treatment with a glutamate antagonist in rats.

  Neuroscience letters 20010202

• Quinoxaline 1,4-dioxides as anticancer and hypoxia-selective drugs.

  Oncology reports 20010101